Wake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences, Winston-Salem, North Carolina.
J Urol. 2013 Nov;190(5):1938-45. doi: 10.1016/j.juro.2013.04.052. Epub 2013 Apr 22.
We measured the long-term efficacy of autologous muscle precursor cell therapy in premenopausal female nonhuman primates with sustained urinary sphincter deficiency.
Urinary sphincter deficiency was created in adult premenopausal female cynomolgus monkeys by selectively cauterizing and then transecting the pudendal innervation to the sphincter complex. The monkeys were then treated (18) or not treated (18) with intra-urinary sphincter injections of 5 million autologous green fluorescent protein labeled skeletal muscle precursor cells. Four untreated, uninjured monkeys served as controls. Maximal urethral pressure measurement and corresponding histological analysis of the structural and cellular components of the sphincter complex were performed up to 12 months after injection.
Cell treatment produced sustained (12 months) increases in resting, somatic nerve stimulated and adrenergic nerve stimulated maximal urethral pressure, and a greater percent of sphincter area occupied by muscle as well as a decrease in the sphincter area occupied by collagen compared to the untreated group (each p>0.05). These results were within control values (each p>0.05). By 3 months after injection green fluorescent protein positive cells were found in the skeletal muscle layer, expressing desmin and connexin-43, and in the smooth muscle layer, expressing α-smooth muscle actin and connexin-43, and they were incorporated into the subendothelial vasculature, expressing Von Willebrand factor. Cell injected sphincter tissue contained a mixture of green fluorescent protein positive cells and predominantly green fluorescent protein negative cells.
Injected skeletal muscle progenitor cells incorporated into the injured sphincter complex resulted in long-term structural and functional restoration of the injured sphincter complex in this nonhuman primate model.
我们测量了自体肌肉前体细胞治疗在持续性尿道括约肌缺陷的绝经前女性非人类灵长类动物中的长期疗效。
通过选择性地烧灼和切断阴部神经对括约肌复合体的支配,在成年绝经前雌性食蟹猴中创建尿道括约肌缺陷。然后,将 500 万个自体绿色荧光蛋白标记的骨骼肌前体细胞经尿道内注射(18 只)或不治疗(18 只)进行治疗。4 只未受伤的未处理的猴子作为对照。在注射后长达 12 个月,进行最大尿道压力测量和对括约肌复合体的结构和细胞成分的相应组织学分析。
细胞治疗产生了持续(12 个月)的静息、躯体神经刺激和肾上腺素能神经刺激最大尿道压力增加,以及括约肌面积的肌肉比例增加,而胶原比例减少与未处理组相比(均 p>0.05)。这些结果在对照值范围内(均 p>0.05)。在注射后 3 个月,在骨骼肌层发现绿色荧光蛋白阳性细胞,表达结蛋白和连接蛋白 43,并在平滑肌层发现绿色荧光蛋白阳性细胞,表达α-平滑肌肌动蛋白和连接蛋白 43,并整合到表达血管性血友病因子的血管内皮下。注射的括约肌组织包含绿色荧光蛋白阳性细胞和主要的绿色荧光蛋白阴性细胞的混合物。
注射的骨骼肌祖细胞整合到受损的括约肌复合体中,导致在这种非人类灵长类动物模型中受损的括约肌复合体的长期结构和功能恢复。